Indore-based Perkant Tech introduces Abhay Parimiti, a portable health assessment device promising rapid diagnostics, amid legal and clinical validation uncertainties.
In a district primary health centre, the first things a patient usually gets are the simplest measures: blood pressure, pulse, oxygen saturation and temperature. Anything more complex often requires a laboratory test and a return visit that many people never make. It is into that gap that Indore-based Perkant Tech is trying to step with Abhay Parimiti, a portable device the company says can produce an automated health assessment in under a minute and be used by a health worker or directly by an individual.
Perkant Tech was founded in June 2020 by Lokant Jain and Saniya Jeswani, who began building the business while in their final year as engineering students during the pandemic. The company says Abhay Parimiti analyses more than 700 body signals and is designed to flag issues linked to cardiac and respiratory health, as well as provide indicators for conditions such as pre-diabetes, haemoglobin, bilirubin and anaemia. It lists the device at ₹20,000, with a seven-inch display, and says manufacturing takes place in Madhya Pradesh and Andhra Pradesh.
The company’s marketing positions the system as a broad diagnostic tool, but that is where the claims become harder to verify. Perkant Tech holds a granted Indian patent and says it has filed in the United States, yet public records do not show U.S. approval, and no peer-reviewed study or independent clinical validation was found for the wider disease-screening claims. There is also no public evidence that the device has clearance from the Central Drugs Standard Control Organisation, India’s medical device regulator, meaning any potential buyer would need to confirm its status directly with the company.
Perkant Tech raised ₹6.6 crore in seed funding in April 2025, led by YourNest Venture Capital, with support from the Atal New India Challenge under NITI Aayog, Villgro Foundation and SanchiConnect. The company said the money would go towards research and development, technology upgrades and commercial launch preparations after pilots it described as successful. It also says the platform aligns with the government’s National Digital Health Mission, while noting that this is a compatibility claim rather than a formal endorsement. The startup joined the Qualcomm Women Entrepreneurs India Network in 2023 and presented the device at the launch of Nokia’s 6G laboratory, but no public customer numbers, deployment figures or revenue data have been disclosed since the fundraising announcement.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
